Akanda (AKAN)
搜索文档
Akanda Corp. Announces Subsequent Registered Direct Offering
newsfilecorp.com· 2024-05-18 03:59
Akanda Corp. Announces Subsequent Registered Direct OfferingMay 17, 2024 3:59 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded wa ...
Akanda Announces Closing of Registered Direct Offering
newsfilecorp.com· 2024-05-18 03:40
Akanda Announces Closing of Registered Direct OfferingMay 17, 2024 3:40 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 2,491,381 common shares at a purchase price of $0.1031 per share, and 21,756,922 pre-funded warrants to purchase 21,756,922 ...
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
newsfilecorp.com· 2024-05-17 22:26
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 17, 2024 10:26 AM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381 common shares at a purchase price of $0.1031 and ...
Akanda Corp receives non-compliance notice from Nasdaq
invezz.com· 2024-05-17 21:30
Akanda Corp (NASDAQ: AKAN) is in focus this morning after receiving a notice of non-compliance from Nasdaq. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.Akanda fails to satisfy the Nasdaq listing requirementsCopy link to sectionThe deficiency notification was issued to the international medical cannabis company because it failed to meet the “minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1). $AKAN failed to sa ...
Why Is Akanda (AKAN) Stock Up 164% Today?
investorplace.com· 2024-05-17 20:02
Akanda (NASDAQ:AKAN) stock is heading higher on Friday despite the cannabis company getting a non-compliance notice from the Nasdaq Exchange.The issue here is AKAN stock not meeting the minimum stockholders’ equity requirement to remain on the Nasdaq Exchange. This requires a minimum stockholders’ equity of $2.5 million. Akanda’s was -$3,828,892 in its latest filing.The Nasdaq Exchange is giving Akanda 45 calendar days, or until June 28, 2024, to submit a plan to regain compliance. If it does so, it may be ...
Akanda Corp. Receives Notice of Non-Compliance from NASDAQ
newsfilecorp.com· 2024-05-17 03:28
Akanda Corp. Receives Notice of Non-Compliance from NASDAQMay 16, 2024 3:28 PM EDT | Source: Akanda CorpLondon, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).According to Nasdaq's listing ...
Akanda (AKAN) - 2023 Q4 - Annual Report
2024-05-02 01:34
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares AKAN The Nasdaq Capital Market FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...
Akanda (AKAN) - 2023 Q4 - Annual Report
2023-12-29 00:00
Exhibit 99.1 Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) As at June 30, December 31, Note 2023 2022 ASSETS Current Cash $ 443,338 $ 228,794 Cash held in trust — 27,009 Trade and other receivables 6 657,568 1,235,619 Prepayments 336,985 199,488 Biological assets 7 257,144 809,180 Inventory 7 1,280,073 1,057,240 Marketable securities 8 270,000 263,691 Total Current Assets 3,245,108 3,821,021 Non-Current Property, plant and equipme ...
Akanda (AKAN) - 2022 Q4 - Annual Report
2023-05-02 00:00
公司财务状况 - 公司是一家刚成立的早期公司,经营历史有限,可能永远无法盈利[14] - 公司在2022年12月31日的营收情况:Bophelo销售了一次大麻花朵给当地买家,收入为31,123美元;Canmart在2022年12月31日的营收约为101,778美元;RPK在2022年12月31日的营收约为1,933,203美元[14] - 公司预计需要额外资金来维持和扩大业务,并发展销售和分销渠道[14] - 公司的财务状况存在继续作为经营实体的疑虑[14] 风险因素 - 公司可能会卷入昂贵且耗时的诉讼事务,可能会损害声誉、业务、财务状况或经营业绩[16] - 公司可能会面临产品责任索赔的固有风险,可能导致增加成本、损害声誉,并对经营业绩和财务状况产生重大不利影响[21] - 公司可能会面临产品召回的固有风险,如果产品因产品缺陷或其他原因召回,可能需要承担召回费用和可能产生的法律诉讼费用[22] - 公司可能会受到全球传染病爆发(如COVID-19)和其他不可预见事件的影响,包括对英国医用大麻产品采购和葡萄牙种植和制造设施建设的负面影响[34] - 公司可能面临网络攻击或数据安全事件,导致安全漏洞、数据泄露或不合规,可能导致收入损失、成本增加、法律责任和声誉损害[35] - 公司可能遭遇计算机黑客入侵、信息安全漏洞、系统瘫痪等安全风险,可能导致信息泄露、系统受损,需要加强安全措施[36] - 公司国际业务面临经济、政治、监管等风险,包括英国脱欧、不同司法管辖区的法律遵从、货币汇率变动等[37] - 英国脱欧可能导致市场波动增加,对公司在欧洲开展业务造成困难,可能影响贸易协议、货币汇率和监管要求[39] - 公司未来国际销售可能受到汇率波动、监管要求和其他障碍的影响,可能导致业务、财务状况和运营结果受损[40] - 公司面临税收法规和税务机构挑战,可能对业务产生重大不利影响,包括全球税收法规变化、税收支出增加等[41] - 公司可能面临劳资纠纷和劳动法变化风险,可能导致额外运营成本增加或改变与员工的关系[44] - 公司在英国和欧洲面临严格的医用大麻监管制度,法律和执法可能快速变化,可能影响公司的经营不确定性[45] 公司业务发展 - 公司需要继续在医疗大麻行业内建立品牌知名度,并对业务战略和生产能力进行重大投资[26] - 公司可能会受到新旧竞争对手在大麻行业中的显著竞争影响,这可能会对公司的业务和财务状况产生负面影响[31] - 公司与Cansativa Group合作,允许Cansativa平台从Sintra的室内种植设施向德国市场供应干花[95] - 公司与国际大麻品牌Cookies签订了独家许可协议,可以在葡萄牙种植、生产和销售Cookies品种的产品[96] 公司财务数据 - 2022年销售额为2,619,682美元,较2021年的41,431美元有显著增长[120] - Canmart Ltd.和RPK在葡萄牙的销售额贡献了2022年的收入[120] - Canmart专注于进口各种CBPM产品,包括医用大麻油和医用大麻花[121] - 2022年销售成本从2020年的1,809美元增加到2021年的43,022美元,再增加到2022年的566,252美元,主要是由于2022年销售活动增加所致[123] - 2022年生物资产公允价值变动收益从2020年的(58,429)美元和2021年的零增加到2022年的1,216,129美元,主要是由于生物资产估值的影响[124] - 2022年摊销和折旧费用从2020年的248,743美元和2021年的478美元增加到2022年的3,598,323美元,主要是由于新增固定资产和无形资产的折旧[125] - 2022年咨询和专业费用从2020年的702,016美元和2021年的1,212,422美元增加到2022年的7,759,824美元,主要是由于Canmart和RPK的运营增加[126] - 2022年人员费用从2020年的1,184,734美元和2021年的374,900美元增加到2022年的6,593,527美元,主要是由于RPK在葡萄牙的种植业务增加[127] - 2022年一般和行政费用从2020年的229,743美元和2021年的170,926美元增加到2022年的3,369,659美元,主要是由于现场活动增加[128] - 2022年利息支出为115,324美元,较2021年的10,509美元和2020年的645,162美元有所增加,主要是由于Akanda和RPK的融资成本增加[130] - 2022年利息收入为886美元,较2021年的90美元和2020年的10,188美元有所增加,主要是由于2022年利息收入增加[132] - 2022年现金流量中,经营活动使用现金为11,469,396美元,较2021年的6,557,062美元有所增加,主要是由于Bophelo和RPK的运营支出增加[137] - 2022年融资活动中,Akanda完成了首次公开发行,募集了总额为16,000,000美元的资金,主要用于固定资产、运营和一般企业用途[138]
Akanda (AKAN) - 2022 Q2 - Quarterly Report
2023-01-04 00:00
Exhibit 99.1 Akanda Corp. Unaudited Condensed Consolidated Statements of Financial Position (Expressed in US Dollars) June 30, December 31, Note 2022 2021 ASSETS Current Cash $ 3,930,702 $ 3,495,390 Cash held in trust 4 472,512 — Trade and other receivables 5 726,865 242,357 Prepayments 380,837 107,759 Biological assets 198,631 — Inventory 895,774 — Financial asset measured at FVTPL 8 337,145 — Total Current Assets 6,942,466 3,845,506 Non-Current Property, plant and equipment 9 12,608,287 1,897,748 Intangib ...